PE
Therapeutic Areas
SeaBeLife Biotech Pipeline
| Drug | Indication | Phase |
|---|---|---|
| SBL03 | Geographic Atrophy in Dry Age-Related Macular Degeneration (AMD) | Pre-clinical |
| Undisclosed | Severe Acute Hepatitis / Fulminant Hepatitis | Pre-clinical |
| Drug | Indication | Phase |
|---|---|---|
| SBL03 | Geographic Atrophy in Dry Age-Related Macular Degeneration (AMD) | Pre-clinical |
| Undisclosed | Severe Acute Hepatitis / Fulminant Hepatitis | Pre-clinical |